New research has shown promise in shrinking tumors in patients with aggressive brain cancer through a new attack strategy. The strategy has been successful in two initial trials.
A recent approach to combat a highly hostile form of brain cancer yielded encouraging results in two studies involving a small group of participants. Researchers announced on Wednesday that they were successful in converting immune cells from patients into “living drugs” that were capable of identifying and targeting glioblastoma cells. In initial experiments, these cells
READ MORE